AUTHORS INFORMATION
Advances in Mind-Body Medicine
Information for Authors
Advances in Mind-Body Medicine (ISSN 1470-3556; electronic ISSN: 1532-1843) is published 6 times per year (January, March, May, July, September, November) by InnoVision Professional Media. Advances publishes one volume per calendar year, which consists of six bimonthly issues. We maintain a publication volume of 45-60 scholarly papers annually. This output reliably represents the full breadth of our scope by exploring the relationship between mind, body, spirit and health; the human experiences of health, illness and medical care; and the clinical, social, and personal implications of a medicine that acknowledges the whole person. Advances looks for fresh thinking, vigorous debate, and careful analysis.
The editors of Advances in Mind-Body Medicine invite authors to submit original papers for consideration. Manuscripts most likely to be accepted for consideration present authoritative information and compelling points of view on the role of psychological, social, and spiritual factors in health promotion and the prevention, treatment, and healing of illness. We are particularly interested in review articles, theoretical models, opinion and commentary, case reports, and research reports. Papers must not be available online, published, or submitted elsewhere for consideration.
Unsolicited submissions are usually acknowledged within 2 weeks of receipt. Advances cannot accept responsibility for lost or mislaid manuscripts. Keep original copies in your possession. All submissions are subject to peer review. Two or more authorities will judge the validity, originality, and significance of the work presented. After the manuscript has been reviewed, the corresponding author will be informed whether it has been accepted for publication, rejected, or requires revision. Authors will be asked to transfer copyright to InnoVision Professional Media (the publisher of Advances) when their manuscripts are accepted for publication. Accepted manuscripts become the property of InnoVision Professional Media and may not be published or be made available online without written permission. If possible, please use MS Word for PC or Mac. All accepted manuscripts are subject to editing to conform to the American Medical Association Manual of Style, 11th edition, as well as accepted journalistic standards. Authors will be asked to review galleys after copyediting and before publication.
Advances is published six times per year in the following months: January, March, May, July, September, and December. We do e-publish articles ahead of print every two weeks. Prior to publication authors must approve the final galley. Advances participates in CLOCKSS for preservation and digital archiving of all published issues. Articles can be published open access upon author request.
Open access article processing charge (APC) information
Articles published in Advances in Mind Body Medicine (ISSN 1470-3556; electronic ISSN: 1532-1843) are subject to payment of an article processing charge (APC) in full open access. An article processing charge (APC) of $2500.00 (US Dollars) applies to papers accepted after peer review. This article processing charge is to cover the costs of peer review, copyediting, typesetting, long-term archiving, and journal management. Once accepted, you’ll receive an invoice that can be paid by credit card, bank transfer, or through institutional channels. Only official invoices issued by InnoVision Professional Media are valid. We do not authorize any third party to collect the APCs. InnoVision Professional Media is the sole service provider and cannot be held liable for actions by third parties.
Submissions
To submit to the journal, e-mail an electronic version to [email protected] and explain why this journal should publish your paper.
Please include the following:
- Title of manuscript
- Running title
- All authors’ full names in publishing order, with degrees, ranks, credentials, and affiliations
- Name, address, telephone (home and work) and fax numbers, and e-mail address of corresponding author
- Current mailing and e-mail addresses for all authors
- If appropriate, institution(s) in which the work was presented
- Key words
- If appropriate, number or name of grant or information about other financial support used to write the article
- Abstract (double-spaced on a separate page) Please use the following PRISMA checklist
- Text (double-spaced, starting on a new page)
- References (dare in AMA format, include a DOI, double-spaced, starting on a new page)
- Tables and figures (starting on a new page—do not integrate into electronic text; they must be separate files on disk)
- Illustrations, original prints only, properly labeled
- Advances Conflict of Interest Disclosure Form
- Advances Copyright transfer form
- Acknowledgments
Contact InnoVision Professional Media with questions or concerns.
Types of Manuscripts to Submit
Visit our manuscript guidelines page for specific information for each article type. Here is a quick summary of article types we consider for publication
Original Research Manuscripts
- Original Research
- Randomized controlled trials (RCTs)
- Brief Reports
- Pilot Studies
Review and Syntheses Manuscripts
- Narrative/ Literature Reviews
- Systematic Review
- Meta-analysis
Clinical and Educational Content
- Case Reports
- Case Series
Non–Peer Reviewed Submissions
Commentary and Opinion
- Editorials
- Perspectives/ Viewpoints
- Letters to the Editor
- Author Reply Letters
- Book Reviews
Manuscript Formatting And Other Details
Manuscript Content
Your manuscript should be formatted according to the International Committee of Medical Journal Editors (ICMJE). You may also find the Consolidated Standards of Reporting Trials (CONSORT) statement helpful for describing a randomized, controlled trial.
Authorship
Disputes over authorship, and multiauthorship in particular, are better resolved early on, preferably before a study begins. The author who is designated as “corresponding author” when the manuscript is submitted will be asked to approve editorial changes to the article on behalf of all authors prior to publication of the article. For more information please visit our Publication Ethics Page.
Ethics
When human experimentation is being reported, include a statement to confirm that the work was done in accordance with the appropriate institutional review body and carried out with the ethical standards set forth in the Helsinki Declaration of 2024. When laboratory animals are used, there should be a statement that the work was carried out according to the National Research Council’s protocol for, or any national law on, the care and use of laboratory animals. For more information please visit our Publication Ethics Page.
Abstracts
Abstracts should be up to 350 words for original research and reviews and are used to summarize the paper. Abstracts are not required for hypotheses, research letters, case reports, editorials, columns or commentaries, book reviews, or other intermittent special publications. Abstracts for original research and reviews should include the following headings whenever possible: Background/Context, Objective, Methods/Design, Setting, Participants, Interventions, Primary Outcome Measures, Results, Conclusions, and Trial Registry information. Please use the following PRISMA checklist. The structure for abstracts is as follows:
- Background: One or two sentences explaining why this study is necessary and important.
- Primary Study Objective: What are the primary study objectives?
- Methods/Design: Outline the key elements of the study design, including a sample size calculation.
- Setting: Where the study was done (how many sites, what kind of sites, etc).
- Participants: Who participated in the study as well as their key demographic characteristics, the dropout rate, adverse events, etc.
- Intervention: The key features of the intervention must be described. Trademarked product name once each in the abstract and body of the text.
- Primary Outcome Measures: What outcome measures were used to measure the primary study objectives. These should be specified in advance (in the trial registry, for example).
- Results: The results of the primary outcomes of the study, such as risk, confidence intervals, numbers needed to treat, or P-values, should be quantified and reported.
- Conclusion: Conclusions supported by the results should be discussed as well as the clinical implications.
References
Start references on a separate page following the text, and number them consecutively in the text by order of appearance. In the text, designate reference numbers either as superscript or on the line in parentheses. (Do not use the footnote or endnote function in Word.) Abbreviate journal titles according to NLM Catalog/PubMed. If in doubt, cite complete journal name. Follow the format and punctuation set forth in the AMA Manual of Style, 11th ed, as illustrated in the following examples. Do not use periods in abbreviations of journal titles. List all authors, but if the number exceeds 6, list the first 3 names followed by “et al.”
- Journal article
- Pert CB, Dreher HE, Ruff MR. The psychosomatic network: foundations of mind-body medicine. Altern Ther Health Med. 1998;4(4):30-41.
- Book chapter
- Schiffman JD. Immunology of influenza. In: Cane MB, ed. Viruses and Influenza. Orlando, Fla: Academic Press; 1990:191-196.
- Book
- Avery GB. Neonatology: Pathophysiology and Management of the Neonate. 3rd ed. Philadelphia, Pa: JB Lippincott; 1987:77-80.
Tables
Number and title tables consecutively in the order in which they are mentioned in the text. Each column within a table should have a heading. Define abbreviations in the legend.
Figures
If you are unable to submit figures electronically, submit 1 copy by post. On the back of the copy note the figure number, last name of the primary author, and orientation (top/left/right). Include the name of the photographer or illustrator, if applicable. In clinical photographs in which the patient can be recognized, include a release signed by the patient or guardian granting permission to publish the photograph. If permission is not obtained, the photograph will be edited to ensure anonymity.
Permissions
If any material in the manuscript is from a prior copyrighted publication, a letter of permission from the copyright holder to reproduce the material should be included. If a photo or illustration does not belong to the author, it must be accompanied by a letter of permission from the copyright holder to reproduce it. Those cited in personal communications (verbal or written) also must grant the author written permission for the use of their names and/or material. For more information please visit our Publication Ethics Page.
Proprietary Interest
All authors must submit a completed and signed Conflict of Interest Disclosure Form disclosing any financial or proprietary interest in the subject matter or materials discussed (eg, employment, stock ownership, honoraria, etc). Manuscripts will not be accepted unless all authors have completed and submitted this form.
Drug Names
Use full generic names only, including inactive moiety. The trade name of a drug may be cited in parentheses the first time the generic name appears.
Abbreviations and Symbols
With the exception of standard units of measurements, avoid abbreviations. Do not use abbreviations in the title or abstract. When using a large number of abbreviations, list them in a table.
Reprints
Upon publication, authors will receive 2 complimentary copies of the issue in which their article appears. If you wish to purchase additional copies or reprints, notify the managing editor when you grant final approval of your edited article.
Timeliness and/or Publication Volume
Advances publishes one volume per calendar year, which consists of six bimonthly issues. We maintain a publication volume of 45-60 scholarly papers annually. This output reliably represents the full breadth of our scope in integrating alternative therapies with conventional medicine while maintaining rigorous, COPE-aligned peer review standards.
Submitting Manuscripts/Manuscript Processing
Please visit our publishing process page for complete information on our publishing process, here is a general outline.
- Peer Review
- Revisions
- Decision
- Accepted Manuscripts / Rejected Manuscripts
- Publication